UCB plots epilepsy expansion with $650M Neurona cell therapy acquisitionnews2026-04-20T01:45:33+00:00April 20th, 2026|Endpoints News|
Three gene therapy pioneers just won the Breakthrough Prize. This is their storynews2026-04-18T23:13:44+00:00April 18th, 2026|Endpoints News|
#AACR26 preview: Revolution Medicines, the RAS bonanza and China ADC standoutsnews2026-04-17T15:38:49+00:00April 17th, 2026|Endpoints News|
Allogene’s first cut of data on ‘off-the-shelf’ CAR-T shows promisenews2026-04-13T15:25:50+00:00April 13th, 2026|Endpoints News|
China biotech’s CRISPR therapy suggests US drugmakers will face competitionnews2026-04-10T15:54:15+00:00April 10th, 2026|Endpoints News|
China-based CAR-T company Oricell raises $40M more as it looks to go publicnews2026-04-10T10:28:17+00:00April 10th, 2026|Endpoints News|
Gilead takes another big swing at expanding beyond HIVnews2026-04-08T15:10:43+00:00April 8th, 2026|Endpoints News|
David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapynews2026-04-08T12:00:17+00:00April 8th, 2026|Endpoints News|
Stipple Bio launches with $100M to find more precise targets on cancer proteinsnews2026-04-06T11:00:13+00:00April 6th, 2026|Endpoints News|
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapynews2026-04-02T18:32:29+00:00April 2nd, 2026|Endpoints News|
